Jeffrey Stein - Dec 29, 2021 Form 4 Insider Report for Cidara Therapeutics, Inc. (CDTX)

Role: President & CEO, Director
Signature: /s/ Jeffrey Stein
Stock symbol: CDTX
Transactions as of: Dec 29, 2021
Transactions value $: $0
Form type: 4
Date filed: 1/7/2022, 07:24 PM
Previous filing: Nov 15, 2021
Next filing: Feb 18, 2022

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	CDTX	Common Stock	Options Exercise	$0	+20K	+4.26%	$0.00	490K	Dec 29, 2021	Direct	F1, F2
holding	CDTX	Common Stock						232K	Dec 29, 2021	By trust
holding	CDTX	Common Stock						42K	Dec 29, 2021	By son

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	CDTX	Restricted Stock Unit	Options Exercise	$0	-20K	-50%	$0.00	20K	Dec 29, 2021	Common Stock	20K		Direct	F3, F4

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The Reporting Person was previously granted restricted stock units to vest upon the achievement of certain milestone events that occurred on December 29, 2021.
F2	Includes 4,000 shares acquired pursuant to the Issuer's Employee Stock Purchase Plan on November 19, 2021.
F3	Each restricted stock unit is the economic equivalent of one share of common stock of the Issuer.
F4	On January 31, 2019, the Reporting Person was granted restricted stock units totaling 60,000 shares subject to vesting upon the achievement of various milestones.